Material manufacturer Xampla has appointed a new chief executive to scale-up the business. Alexandra French, an experienced chemist with a degree in natural sciences from the University of Cambridge, has joined Xampla to lead it through the next phase of growth. She has extensive experience after 25 years at specialty chemicals company, Johnson Matthey, where she held a variety of senior leadership, commercial, operation and technical roles, and her most recent role leading operations at AIM listed company, Titon, across the UK, Europe, the US and South Korea. French will spearhead…

Press release Macomics Announces the Appointment of Kevin Lee as Independent Non-Executive Director Edinburgh and Cambridge, UK, 19 October 2023 - Macomics Ltd, a leader in macrophage drug discovery, announces that it has appointed Kevin Lee Ph.D., MBA as Independent Non-Executive Director. Based in the UK and CEO of Cambridge, UK/Cambridge, US based, Bicycle Therapeutics (NASDAQ: BCYC), Kevin brings two decades of biotech and pharma experience to Macomics. In addition to his seat on Bicycle’s board of directors, he is also a non-executive director of Alchemab Therapeutics Ltd. Kevin has…

Pioneering partnership to drive development of new tests and treatments to tackle deadly antimicrobial resistance, which could otherwise kill 10 million a year by 2050 Innovate UK, LifeArc, and Medicines Discovery Catapult (MDC) have joined forces to create PACE (Pathways to Antimicrobial Clinical Efficacy), a £30 million initiative supporting early-stage innovation against antimicrobial resistance (AMR) to save lives. PACE has today (19 October 2023) announced its first funding call with up to £10 million available to support innovators developing new antimicrobials. As the UK's…

The next UCL SysMIC online course in coding, modelling & data analysis, will start on Monday 6th November 2023. Participants will become confident in using the Python, R and MATLAB platforms, developing interdisciplinary skills that will make them more effective researchers with the confidence to develop and apply computational techniques in modelling and data analysis to their own work. Our materials were designed by bio-scientists, for bio-scientists and are focused on biological applications and practical approaches that let participants develop coding and analysis skills while…

The new ABLE 3D Magnetic Stir and Disposable Bioreactor System from AMSBIO provides cost-effective, lab-scale production of induced pluripotent stem (iPS) cell spheroid culture. Induced pluripotent stem cells grown in 3D spheroid suspension culture closely resemble embryoid body structures naturally formed by embryonic stem cells. Using an ABLE 3D Bioreactor offers researchers an easy-to-use and affordable tool that provides excellent yield, viability, and high efficiency for the expansion of human iPS stem cells and differentiation. Made of high-density polycarbonate for biocompatibility…

Are you a scientist or clinician working in the wonderful world of cell and gene therapy and drug development? If yes, this is the podcast for you! During this episode of 'Conversations in Drug Development' you can learn more about the 'Recent Trends in Oncology Drug Development'. LISTEN NOW 

Aimed at in-house lawyers who are not already experts in a given technology but would like to know more, each of these three sessions will give an overview of the science as well as jargon-busting tips, followed by some legal considerations and hot topics.To find out more and register, click here - https://www.bristows.com/viewpoint/events/

  Latest News RS&RS Scientific and Native Labs are the latest start-ups to join Stevenage Bioscience Catalyst's (SBC) Lab Hotel. Read more Tessellate BIO Emerges from Stealth. Read more Cryoport and Cell and Gene Therapy Catapult Announce Strategic Collaboration at Stevenage Manufacturing Innovation Centre for Advancement of Cell and Gene Therapies. Read more   Learn more about SBC: https://www.stevenagecatalyst.com/about/  

SemaCyte Microcarrier Platform addresses limitations within adherent cell assays to accelerate the pace of in vitro drug discovery Early access will further validate the technology and provide feedback on applicability across customer workflows   Cambridge, UK, 18 October 2023: Semarion Ltd, a University of Cambridge spin-out company from the Cavendish Laboratory combining materials engineering and cell biology to tackle unmet drug screening needs, today announced the opening of its Early Adopter Programme for its SemaCyte® Microcarrier Platform. The platform overcomes current…

Research published in Molecular Cell used INDUCE-seq to identify DNA topology as an important regulator of CRISPR targeting specificity Peer-reviewed data demonstrates the sensitivity of INDUCE-seq DNA break mapping platform, in identifying topology-related off-target events across the genome in cells   Cambridge, UK, 18 October 2023: Broken String Biosciences (“Broken String”), a genomics company building a technology platform to drive the development of cell and gene therapies that are safer by design, today announced that its INDUCE-seq™ DNA break-mapping technology had been used in…